A Cross‐Organ Symphony of Human Immune System Maturation

The classical understanding of fetal immunology has long been one of deliberate quiescence: a strategically suppressed immune system designed to avoid conflict with the maternal allograft while establishing self-tolerance 1, 2. In a recent article in Cell, He et al. counter this interpretation with an unprecedented multi-organ single-cell atlas encompassing 2.87 million immune cells from 23 anatomically diverse sites across 15 second-trimester human fetuses (12–25 weeks post-conception) and four adults 3. The picture that emerges is not of silence but of a highly orchestrated, systemic, and cross-organ immune program choreographing activation, migration, tolerance, and memory formation long before birth. Far from being an immature sketch of the adult immune system, the second-trimester fetus operates a sophisticated, body-wide immune network whose cellular and molecular fingerprints persist into adulthood, showing that immune maturation is profoundly cross-organ in nature. Immune cell maturation is not confined to privileged sites. He et al. discovered a broad precursor T cell distribution across multiple fetal organs; these extrathymic precursor (ET) T cells exhibit intermediate features between thymic progenitor (TP) and mature naive CD4+ T cells. There is a clear lineage differentiation from TP to ET cells, which then bifurcate into mature naive regulatory (Treg) and CD4+ T cells, implying that TP cells circulate to multiple organs and then mature throughout fetal development 3. This illustrates an inter-organ pathway of immune cell differentiation between the thymus and other fetal organs. Another striking discovery at the organ level is that memory and activated T cell populations are widely present across fetal organs, including Tregs as well as effector memory, effector, and tissue-resident memory (TRM) cells, supporting a more active immune response across multiple organs in second-trimester fetuses that challenges the long-held view of fetal T cell immune quiescence. The proportion of memory and activated T cells increases with developmental progression across organs. T cell receptor (TCR) repertoire analysis identified preferential activation of CD4+ and CD8+ T cells within specific organs, such as the stomach, sigmoid colon, jejunum, and duodenum 3, perhaps owing to their unique local microenvironments. Leveraging multi-organ sequencing, He et al. further show that TRM populations, like effector and effector memory T cells, display TCR sharing across multiple barrier organs in both fetuses and adults (though to a lesser extent in fetuses). Adult CD4+ TRM cells share TCRs across the esophagus, trachea, and stomach, while CD8+ TRM clones spanned the intestines, bladder, esophagus, trachea, stomach, and lymph nodes 3. This indicates that TRM cells exchange between various anatomical sites, contributing to local and systemic immunity, contradicting the conventional understanding that they are confined to specific organs and barrier sites for localized immunity. TCR clone sharing in fetuses indicated that antigen-experienced or pre-primed T cells migrate extensively across anatomical barriers long before birth, consistent with the previous studies 4, 5, contributing greatly to adaptive immune system establishment; such observations would have been missed by single-organ or fetal liver + thymus + spleen-focused studies. The tolerance machinery uncovered by He et al. underscores the necessity of organ-level investigations. Specifically, they identified a dominant ARG1+ neutrophil population present at high frequency in nearly all fetal organs but nearly absent in adults. These cells, together with the PTGES3/PTGER4 signaling axis governed by stromal and immune elements, actively suppress T cell expansion and activation 3, differ from previously reported polymorphonuclear myeloid-derived suppressor cell pathway 6. The strength of this tolerogenic program varies by organ; fetal bone marrow, skin, and liver show high ARG1+ neutrophil infiltration 3, consistent with their roles in maternal blood interaction and early microbial colonization 4, 7. Only multi-organ-level studies could discover this distributed, organ-tuned tolerance network that prevents fetal anti-maternal or anti-self reactivity while allowing immune maturation. The authors also uncovered widespread functional hematopoietic stem cell (HSC) distribution across various fetal organs. Classical hematopoietic sites are restricted to the yolk sac, liver, and bone marrow during early development 8. He et al. revealed that functional HSCs disperse across multiple other fetal organs, including the heart, kidney, muscle, skin, esophagus, pancreas, and lungs. These extra-medullary HSCs are not merely vestigial; heart-derived HSCs generate mast and erythroid cells, whereas liver-derived HSCs preferentially differentiate toward monocytes, macrophages, neutrophils, and dendritic cells, indicating divergent differentiation potentials across organs 3. The second trimester includes a transient but widespread diffuse hematopoietic phase that seeds nascent organs with local immune effectors. This widespread, organ-autonomous hematopoiesis explains how the rapidly expanding fetal immune system can scale so quickly without relying solely on bone marrow output. The implications of this cross-organ research are profound. First, they refute outdated notions that the fetus is immunologically null or that immune maturation occurs in isolated compartments. Second, they explain why preterm infants often display surprisingly mature immune responses in peripheral tissues, despite having an immature thymus. Third, they offer insight into systemic tolerance mechanisms; ARG1+ neutrophils and the PTGES3/PTGER4 axis are recruited to prevent excessive T cell activation during fetal development, which builds the delicate balance between immune activation and tolerance alongside T cell activation. Fourth, functional HSCs are widely distributed across fetal organs that are capable of differentiating into diverse immune cell lineages, implying their distinct origins or differentiation stages within different organs. The transient diffuse hematopoiesis described in this study offers a new lens on congenital hematological disorders and childhood leukemia, many of which originate in infancy and may exploit these non-canonical stem-cell niches. The sheer scale of the atlas, including 23 organs and multiple fetal donors with matched adult controls, provides statistical power that fragmented studies were unable to achieve. Hierarchical clustering and principal component analysis of whole-transcriptome profiles reveal similarities and differences between the embryonic stage and adulthood. Fetal organs already contain immune cell types resembling adult counterparts, indicating that the immune system is highly proliferative in the second trimester, albeit immature. TCR repertoire analysis across dozens of sites uncovered the extensive clonal sharing and dynamic cross-organ trafficking of memory T cells in utero. These global developmental signatures would have remained hidden without cross-organ comparison. Additionally, the public data portals of this study will serve as an invaluable research resource. In conclusion, He et al. deliver the most comprehensive map of human immune ontogeny to date and force a fundamental rewriting of developmental immunology. The second-trimester human fetus does not assemble its immune system organ-by-organ; it conducts a body-wide, temporally restricted symphony in which hematopoietic stems disperse, T cell clones migrate across distant tissues, and tolerance circuits are deployed globally to restrain excessive activation. Their findings indicate that the adult immune system is not built from scratch at birth but is sculpted from a pre-existing, highly interconnected fetal template. This cross-organ view of immune ontogeny closes a long-standing chapter on fetal immune privilege while opening an entirely new field: the systematic study of how prenatal immune wiring influences health and disease throughout life. Just as the Human Cell Atlas project 9 has shown that cell types and states can only be fully defined in the context of all tissues, this fetal immune atlas proves that immune maturation trajectories, tolerance networks, hematopoietic output, and antigen-experienced cell trafficking are intrinsically multi-organ processes. Future investigations into immune changes across human development, autoimmune diseases, and carcinogenesis must adopt similarly systemic, organ-inclusive designs. Studying the immune system at the organ level could elucidate the pathogenesis of human immunity disorders and cancer, as well as provide innovative therapeutic strategies. Zhan-Li Chen: conceptualization, writing–original draft, writing –review & editing, validation, formal analysis. The author has nothing to report. The author has nothing to report. The author has nothing to report. The author has nothing to report. The author declares no conflicts of interest. Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.